113 related articles for article (PubMed ID: 23330355)
1. Medulloblastoma: molecular classifications and prognostic associations.
Shrieve DC; Colman H
Oncology (Williston Park); 2012 Nov; 26(11):1097, 1102. PubMed ID: 23330355
[No Abstract] [Full Text] [Related]
2. A tale of two tumors: pediatric and adult medulloblastoma.
Aizer AA; Chan AW
Oncology (Williston Park); 2012 Nov; 26(11):1095-7. PubMed ID: 23330354
[No Abstract] [Full Text] [Related]
3. Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers.
Shonka N; Brandes A; De Groot JF
Oncology (Williston Park); 2012 Nov; 26(11):1083-91. PubMed ID: 23330353
[TBL] [Abstract][Full Text] [Related]
4. Perspectives in the management of central nervous system tumours.
Ansari BM
Indian J Pediatr; 1993; 60(2):237-43. PubMed ID: 8244498
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
Harris RD; Richard MA; Gramatges MMJ; Wilhelm K; Scheurer ME; Lupo PJ; Brown AL
Pediatr Hematol Oncol; 2023 May; 40(4):407-411. PubMed ID: 35862575
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma/Primitive neuroectodermal tumor and germ cell tumors: the uncommon but potentially curable primary brain tumors.
Samkari A; Hwang E; Packer RJ
Hematol Oncol Clin North Am; 2012 Aug; 26(4):881-95. PubMed ID: 22794288
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care in adult medulloblastoma: results of an international online survey.
Cosman R; Brown CS; DeBraganca KC; Khasraw M
J Neurooncol; 2014 Oct; 120(1):125-9. PubMed ID: 25026996
[TBL] [Abstract][Full Text] [Related]
10. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
11. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastomas-primitive neuroectodermal tumours in the adult population.
Smee RI; Williams JR
J Med Imaging Radiat Oncol; 2008 Feb; 52(1):72-6. PubMed ID: 18373831
[TBL] [Abstract][Full Text] [Related]
13. Primitive neuroectodermal tumors/medulloblastoma.
Weil MD
Curr Neurol Neurosci Rep; 2002 May; 2(3):205-9. PubMed ID: 11936998
[TBL] [Abstract][Full Text] [Related]
14. Role of spinal MRI in the follow-up of children treated for medulloblastoma.
Bartels U; Shroff M; Sung L; Dag-Ellams U; Laperriere N; Rutka J; Bouffet E
Cancer; 2006 Sep; 107(6):1340-7. PubMed ID: 16894528
[TBL] [Abstract][Full Text] [Related]
15. [Molecular biological study of cerebellar medulloblastoma and supratentorial primitive neuroectodermal tumors].
Xuan Q; Xu QZ
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):271-3. PubMed ID: 14518436
[No Abstract] [Full Text] [Related]
16. Risk factors of recurrence in 157 MB/PNET patients treated in one institution.
Perek D; Perek-Polnik M; Drogosiewicz M; Dembowska-Bagińska B; Roszkowski M; Barszcz S
Childs Nerv Syst; 1998 Oct; 14(10):582-6. PubMed ID: 9840383
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma and primitive neuroectodermal tumors.
Packer RJ; Macdonald T; Vezina G; Keating R; Santi M
Handb Clin Neurol; 2012; 105():529-48. PubMed ID: 22230517
[TBL] [Abstract][Full Text] [Related]
18. [Evolution of the management of pediatric and adult medulloblastoma].
Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
[TBL] [Abstract][Full Text] [Related]
19. Current treatment approaches for infants with malignant central nervous system tumors.
Lafay-Cousin L; Strother D
Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475
[TBL] [Abstract][Full Text] [Related]
20. [CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report].
Sato H; Shibuya K; Koizumi T; Kato S; Endo S
No Shinkei Geka; 2014 Jul; 42(7):641-50. PubMed ID: 25006105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
